Results 171 to 180 of about 172,875 (307)
Late-presenting congenital anterior urethral diverticulum causing renal impairment in a male child. [PDF]
Houas Y, Zouaoui A, Jouini R.
europepmc +1 more source
Harnessing the Biological Responses Induced by Nanomaterials for Enhanced Cancer Therapy
Nanomaterial (NM)‐induced toxicity can be strategically repurposed for cancer therapy. This review summarizes the mechanism by which NMs selectively activate specific cellular processes to regulate cell fate independently. We also discussed how NMs‐induced biological responses can be leveraged as therapeutic strategies for cancer treatment.
Liting Wang+6 more
wiley +1 more source
Development and validation of a predictive model for in-hospital mortality in patients with coronary heart disease and renal insufficiency. [PDF]
Li Y+11 more
europepmc +1 more source
PARATHYROID HYPERPLASIA IN RENAL INSUFFICIENCY [PDF]
Tracy B. Mallory, Benjamin Castleman
openaire +3 more sources
By employing new protein‐templated AIEgen Ir@BSA as the phosphorescence signal indicator and papain as the biomolecular recognition element, a straightforward protocol for Cys C quantitation has been developed. On‐site quantitation of Cys C in clinical serum samples has been successfully demonstrated using a smartphone‐based portable phosphorescence ...
Shuqi Xia+7 more
wiley +1 more source
Recurrent immunotactoid glomerulopathy in a kidney transplant recipient: Case report. [PDF]
Yu S+6 more
europepmc +1 more source
ABSTRACT Cardiovascular complications are the leading cause of mortality in sickle cell anemia (SCA) patients. While extensive data have identified diastolic dysfunction (DD) to increase morbidity and mortality, the unique hemodynamic conditions inherent to SCA challenge the current recommendations to assess diastolic function. Thus, there is an urgent
Théo Simon+20 more
wiley +1 more source
Concomitant Immune Checkpoint Inhibitors Induced Central and Primary Adrenal Insufficiency: A Diagnostic Challenge. [PDF]
Nascè A+4 more
europepmc +1 more source
ABSTRACT Breakthrough hemolysis (BTH) is defined as a hemolytic exacerbation in a patient with paroxysmal nocturnal hemoglobinuria (PNH) treated with complement inhibitors (CIs). In the current era of several terminal and proximal inhibitors, there are no guidelines for defining BTH and its severity, and clinical management is not standardized.
Bruno Fattizzo+23 more
wiley +1 more source
Prognostic Value of Geriatric Characteristics in Allogeneic Haematopoietic Stem Cell Transplant Recipients Aged Over 60 Years. [PDF]
Lee XH+10 more
europepmc +1 more source